Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of adding metformin to sitagliptin in Japanese patients with type 2 diabetes mellitus
jRCT2080221725Phase 3
- Sponsor
- Merck & Co.
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Sitagliptin + metformin with Sitagliptin + placebo (2 arms).
02
Drugs
sitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221725.